Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,085,108
+$8,657,554 QoQ
Shares Held
76,197
-1.4% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names. LGND ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,085,108 | 76,197 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $15,427,554 | 77,273 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,578,773 | 98,264 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $17,934,184 | 101,243 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,469,899 | 109,693 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,356,038 | 127,031 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $10,254,683 | 95,704 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,402,954 | 93,945 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,429,454 | 100,041 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,501,018 | 116,293 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,611,585 | 106,575 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $8,115,743 | 135,443 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,533,376 | 146,094 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,748,758 | 132,528 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $9,023,142 | 135,077 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,400,950 | 144,013 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,394,764 | 150,132 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,525,540 | 111,348 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,307,235 | 112,050 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,426,337 | 110,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,956,131 | 91,136 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $14,049,481 | 92,158 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,724,399 | 168,169 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $19,669,660 | 206,354 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $51,073,602 | 456,626 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $24,096,549 | 331,361 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||